Impaired insulin secretion is a hallmark in both type I and type II di
abetic individuals. Whereas type I (insulin-dependent diabetes mellitu
s) implies p-cen destruction, type II (non-insulin dependent diabetes
mellitus), responsible for 75% of diabetic syndromes, involves diminis
hed glucose-dependent secretion of insulin from pancreatic beta-cells.
Although a clear demonstration of a direct effect of 17 beta-estradio
l on the pancreatic P-cen is lacking, an in vivo insulinotropic effect
has been suggested. In this report we describe the effects of 17 beta
-estradiol in mouse pancreatic p-cells. 17 beta-Estradiol, at physiolo
gical concentrations, closes K-ATP channels, which are also targets fo
r antidiabetic sulfonylureas, in a rapid and reversible manner. Furthe
rmore, in synergy with glucose, 17 beta-estradiol depolarizes the plas
ma membrane, eliciting electrical activity and intracellular calcium s
ignals, which in turn enhance insulin secretion. These effects occur t
hrough a receptor located at the plasma membrane, distinct from the cl
assic cytosolic estrogen receptor. Specific competitive binding and lo
calization of 17 beta-estradiol receptors at the plasma membrane was d
emonstrated using confocal reflective microscopy and immunocytochemist
ry. Gaining deeper knowledge of the effect induced by 17 beta-estradio
l may be important in order to better understand the hormonal regulati
on of insulin secretion and for the treatment of NIDDM.